- ￥378 - 1701.25
- TargetMol
- USA
- T1502
- 2025年07月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
-20°C
- 保质期：
For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -1541℃ for several months.
- 英文名：
Vildagliptin (LAF-237)
- 库存：
详询
- 供应商：
详询
- CAS号：
274901-16-5
- 规格：
2mg/10mg/25mg/1ml/10mM
| 规格： | 2mg | 产品价格： | ￥378.0 |
|---|---|---|---|
| 规格： | 10mg | 产品价格： | ￥964.0 |
| 规格： | 25mg | 产品价格： | ￥1701.25 |
| 规格： | 1ml/10mM | 产品价格： | ￥658.0 |
ID：T1502
PURITY：0.985
Formula：C17H25N3O2
MolWt：303.4
Appearance：白色粉末
Solubility：G4Soluble in DMSO
Bioactivity：Vildagliptin, previously identified as LAF237, is a new oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucaon release by the alpha cells of the islets of Langerhans in the pancreas. It is currently in clinical trials in the U.S. and has been shown to reduce hyperglycemia in type 2 diabetes mellitus. While the drug is still not approved for use in the US, it was approved in Feb 2008 by European Medicines Agency for use within the EU and is listed on the Australian PBS with certain restrictions.
Status：
Pathways：Proteases/Proteasome
Target：DPP-4 inhibitor
Receptor：DDP-4
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
